iShares Biotechnology ETF
IBB
NASDAQ
Weiss Ratings | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C- | |||
Valuation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Price | $125.89 | |||
Company Info | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | iShares | |||
Manager/Tenure (Years) | Greg Savage (16), Jennifer Hsui (11), Paul Whitehead (2) | |||
Website | http://www.ishares.com | |||
Phone Number | 800-474-2737 | |||
Fund Information | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | iShares Biotechnology ETF | |||
Category | Health | |||
Sub-Category | Healthcare Sector Equity | |||
Prospectus Objective | Specialty - Technology | |||
Inception Date | Feb 05, 2001 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | -- | |||
Minimum Subsequent Investment | -- | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 0.30% | |||
Dividend | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 0.69% | |||
Asset Allocation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 0.14% | |||
Stock | 99.86% | |||
U.S. Stock | 90.91% | |||
Non-U.S. Stock | 8.95% | |||
Bond | 0.00% | |||
U.S. Bond | 0.00% | |||
Non-U.S. Bond | 0.00% | |||
Preferred | 0.00% | |||
Convertible | 0.00% | |||
Other Net | 0.00% | |||
Price History | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -4.55% | |||
30-Day Total Return | -6.82% | |||
60-Day Total Return | -7.18% | |||
90-Day Total Return | -6.34% | |||
Year to Date Total Return | -7.21% | |||
1-Year Total Return | -4.79% | |||
2-Year Total Return | -0.27% | |||
3-Year Total Return | -17.22% | |||
5-Year Total Return | 22.00% | |||
Price | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | $125.89 | |||
1-Month Low Price | $125.89 | |||
1-Month High Price | $137.79 | |||
52-Week Low Price | $112.41 | |||
52-Week Low Price (Date) | Oct 27, 2023 | |||
52-Week High Price | $140.89 | |||
52-Week High Price (Date) | Feb 27, 2024 | |||
NAV | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
1-Month Low NAV | $125.90 | |||
1-Month High NAV | $137.78 | |||
52-Week Low NAV | $112.41 | |||
52-Week Low NAV (Date) | Oct 27, 2023 | |||
52-Week High NAV | $140.86 | |||
52-Week High Price (Date) | Feb 27, 2024 | |||
Beta / Standard Deviation | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | -- | |||
Standard Deviation | 18.59 | |||
Balance Sheet | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 7.63B | |||
Operating Ratios | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.45% | |||
Turnover Ratio | 13.00% | |||
Performance | IBB - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 32.47% | |||
Last Bear Market Total Return | -9.59% | |||